Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Amicus Therapeutics (FOLD) Receivables - Other (2018 - 2019)

Amicus Therapeutics (FOLD) has disclosed Receivables - Other for 2 consecutive years, with $9.0 million as the latest value for Q1 2019.

  • For the quarter ending Q1 2019, Receivables - Other changed N/A year-over-year to $9.0 million, compared with a TTM value of $9.0 million through Mar 2019, changed N/A, and an annual FY2018 reading of $9.0 million, changed N/A over the prior year.
  • Receivables - Other was $9.0 million for Q1 2019 at Amicus Therapeutics, roughly flat from $9.0 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $9.0 million in Q4 2018 and bottomed at $9.0 million in Q4 2018.